User:Jamie Nunziata/Notebook/Biomaterial Design 2016/2016/04/12: Difference between revisions
Line 13: | Line 13: | ||
==Protocol== | ==Protocol== | ||
<b>FTIR potassium bromide pellets were made using the following procedure: </b><br> | <b>FTIR potassium bromide pellets were made using the following procedure: </b><br> | ||
250 mg of KBr was dissolved in approximately 25mL of 11-mercaptoundacanamide, 11-mercapto-1-undecanol, lysozyme, and citrate gold nanoparticles. The samples were frozen with liquid nitrogen and lyophilized for two days. | 250 mg of KBr was dissolved in approximately 25mL of 11-mercaptoundacanamide, 11-mercapto-1-undecanol, lysozyme, and citrate gold nanoparticles. The samples were frozen with liquid nitrogen and lyophilized for two days. The samples were then pelleted and analyzed using Bruker Alpha FT-IR Spectrometer. | ||
<br><br> | <br><br> | ||
<b>ICP was performed using the following:</b><br> | <b>ICP was performed using the following:</b><br> |
Revision as of 19:20, 3 May 2016
Project name | <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> |
ObjectiveToday's objective includes the following:
ProtocolFTIR potassium bromide pellets were made using the following procedure:
DataFigure 1: FTIR of functionalized Gold Nanoparticles
|